Evidence Hub

Infective endocarditis complicated with multiple cerebral embolism and hemorrhage caused by Streptococcus sinensis: a rare case report and literature review

Zheng H, He C, Tang K, Wang X, Xie L, Li W, Wu J, Zhao D

Frontiers in medicine, 2026

Abstract

Streptococcus sinensis (S. sinensis) is a rare pathogen causing infective endocarditis (IE). We report a 68-year-old Chinese man with S. sinensis-associated IE complicated by cerebral infarction with hemorrhagic transformation. He presented with fever, aphasia, arthralgia, arthritis, and right hemiparesis. Initial transthoracic echocardiography was negative for vegetations; valve-adjacent vegetations were identified until after neurological stabilization. Antimicrobial therapy was adjusted iteratively according to culture and susceptibility results. Linezolid plus cefazolin for 4 weeks achieved his condition stabilization; the patient declined valve replacement and was discharged. Oral linezolid plus moxifloxacin was continued for another 4 weeks, with sustained stability. S. sinensis IE can involve the central nervous system. Early pathogen identification and targeted antimicrobial therapy are crucial for better outcomes.

How strong is the evidence?

Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free